Amnis Corporation
Seattle, Washington, United States
About Amnis Corporation
Amnis manufactures and supplies flow cytometry products and services. Their technology is used in research and clinical studies with biomedical and therapeutic applications, including investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $21.9M
- Last round: Series Unknown (Jul 2009)
- Website: amnis.com
- Phone: +1 206 374 7000
Industries & Categories
Biotechnology, Manufacturing, Retail
Social Profiles
Canonical: https://fsome.com/organization/amnis-corporation-2567290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.